Cite
HARVARD Citation
Lipton, A. et al. (2016). Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. European journal of cancer. pp. 75-83. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lipton, A. et al. (2016). Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. European journal of cancer. pp. 75-83. [Online].